CollPlant Biotechnologies (CLGN) Payables (2017 - 2025)
CollPlant Biotechnologies (CLGN) posted Payables of $610000.0 for Q4 2025, down 1.29% on a QoQ basis from $618000.0 in Q3 2025, and down 29.89% year-over-year from $870000.0 in Q4 2024.
CollPlant Biotechnologies (CLGN) Payables (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies' Payables history runs 9 years deep, the most recent figure standing at $610000.0 for Q4 2025.
- Quarterly Payables fell 29.89% year-over-year to $610000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $610000.0 (down 29.89% YoY) and the FY2025 annual result came in at $610000.0, down 29.89% from the prior year.
- Payables was $610000.0 for Q4 2025 at CollPlant Biotechnologies, down from $618000.0 in the prior quarter.
- Across five years, Payables topped out at $1.1 million in Q2 2024 and bottomed at $571000.0 in Q2 2025.
- A 5-year average of $872315.8 and a median of $880000.0 in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2024 — Payables soared 49.15% — and 2025, when it plunged 49.82%.
- CollPlant Biotechnologies' Payables stood at $1.0 million in 2021, then gained by 9.57% to $1.1 million in 2022, then retreated by 13.5% to $980000.0 in 2023, then fell by 11.22% to $870000.0 in 2024, then fell by 29.89% to $610000.0 in 2025.
- Business Quant data shows CLGN's Payables at $610000.0 in Q4 2025, $618000.0 in Q3 2025, and $571000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,913.26 Bn | 1,913.20 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 8.69 Mn |
| 4 | BeOne Medicines | 471.02 Bn | 466.23 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 122.17 Bn | 114.92 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.10 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.60 Bn | 50.42 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Alnylam Pharmaceuticals | 37.39 Bn | 34.38 Bn | 959.66 Mn | 126.63 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 610,000.00 |
| Sep 30, 2025 | 618,000.00 |
| Jun 30, 2025 | 571,000.00 |
| Dec 31, 2024 | 870,000.00 |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 980,000.00 |
| Sep 30, 2023 | 744,000.00 |
| Jun 30, 2023 | 763,000.00 |
| Mar 31, 2023 | 885,000.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 880,000.00 |
| Jun 30, 2022 | 760,000.00 |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 865,000.00 |
| Jun 30, 2021 | 698,000.00 |
| Mar 31, 2021 | 894,000.00 |
| Dec 31, 2020 | 798,000.00 |